Related Experiment Videos
Considerations in dosage selection for third generation cephalosporins.
J H Yuk-Choi1, C H Nightingale, T W Williams
1Department of Pharmacy Services, Methodist Hospital, Baylor College of Medicine, Houston, Texas.
Clinical Pharmacokinetics
|February 11, 1992
Summary
Third generation cephalosporins require individualized dosing due to varying pharmacokinetics. Optimizing dosage ensures effective treatment by maintaining drug concentrations above minimum inhibitory levels, especially in specific patient populations.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Third-generation cephalosporins exhibit diverse pharmacokinetic profiles, necessitating tailored dosing strategies.
- Their efficacy against aerobic Gram-negative organisms is influenced by a limited post-antibiotic effect, requiring sustained therapeutic concentrations.
Purpose of the Study:
- To analyze the pharmacokinetic variability of third-generation cephalosporins.
- To guide optimal dosage regimens considering patient-specific factors and infection sites.
Main Methods:
- Review of pharmacokinetic data for third-generation cephalosporins.
- Analysis of factors influencing drug disposition, including protein binding, renal/hepatic function, and patient age.
Main Results:
- Pharmacokinetic parameters differ significantly among third-generation cephalosporins.
- Renal function impacts elimination; hepatic disease generally does not require dose adjustment.
- Altered protein binding and target site concentrations necessitate dosage modifications.
Conclusions:
- Individualized dosage adjustment is crucial for third-generation cephalosporins.
- Consideration of patient-specific factors (renal function, age, disease state) and target site concentrations is essential for optimizing therapeutic outcomes.